Phosphonic acids represent a potent, yet underexploited, group of bioactive compounds with great promise in the treatment of human disease. A wide variety of phosphonates are produced in nature and many have useful bioactive properties. Importantly, the biological targets of phosphonic acids vary substantially, allowing them to be used for treating a variety of health conditions. In our initial funding period we showed that phosphonate biosynthesis is surprisingly common in nature and that a wealth of uncharacterized natural products await characterization. Armed with these results, we are now ready to move fully into the discovery and development phase of the project. In the next five years we expect to characterize a large number of novel phosphonate compounds. Their chemical structures will be determined, their bioactivity profiles assessed and their biosynthetic pathways elucidated. We will use this information to develop strains that efficiently and economically produce the most useful candidates. The proposed Program Project addresses each of these topics via a multidisciplinary research program involving microbiology, biochemistry, chemistry, metabolic engineering and structural biology. We propose four intertwined research projects to discover, design and develop novel and known phosphonic acid antibiotics. The first project involves discovery, sequencing and characterization of gene clusters encoding phosphonic add biosynthesis using genomics, microbial genetics and molecular biology. The second project is focused on structural elucidation of the wealth of new compounds that have been discovered in the current funding period and on the biochemical reconstruction of the biosynthetic pathways of phosphonic acid antibiotics. The third project will focus on structural biology and enzymology of unusual catalysts involved in phosphonate biosynthesis and the various resistance determinants that may be utilized to overcome the biological activities of phosphonates. The fourth project will employ cutting-edge synthetic biology approaches to engineer both natural and designed phosphonic acid biosynthetic pathways for economical production of medically and industrially important phosphonic acid compounds. Each of the four projects will be aided by an Analytical Core resource that will provide modern mass-spectrometry and nuclear magnetic resonance instrumentation and technical support. The entire project will be housed in the new Institute for Genomic Biology at the University of Illinois, where the program project team occupies a single, large contiguous, laboratory.

Public Health Relevance

The proposed research is designed to discover novel bioactive compounds that will have useful pharmaceutical properties. These may be of use in the treatment of antibiotic resistant pathogens and other human ailments. The proposed research is also very likely to generate new knowledge regarding the biochemistry of phosphorus containing small molecules.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM077596-07
Application #
8457035
Study Section
Special Emphasis Panel (ZRG1-BCMB-U (40))
Program Officer
Gerratana, Barbara
Project Start
2007-04-10
Project End
2017-03-31
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
7
Fiscal Year
2013
Total Cost
$1,515,652
Indirect Cost
$520,400
Name
University of Illinois Urbana-Champaign
Department
Genetics
Type
Organized Research Units
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Zhao, Huimin; Medema, Marnix H (2016) Standardization for natural product synthetic biology. Nat Prod Rep 33:920-4
Chekan, Jonathan R; Cogan, Dillon P; Nair, Satish K (2016) Molecular Basis for Resistance Against Phosphonate Antibiotics and Herbicides. Medchemcomm 7:28-36
Zhang, Mingzi M; Wang, Yajie; Ang, Ee Lui et al. (2016) Engineering microbial hosts for production of bacterial natural products. Nat Prod Rep 33:963-87
Goering, Anthony W; McClure, Ryan A; Doroghazi, James R et al. (2016) Metabologenomics: Correlation of Microbial Gene Clusters with Metabolites Drives Discovery of a Nonribosomal Peptide with an Unusual Amino Acid Monomer. ACS Cent Sci 2:99-108
Ulrich, Emily C; van der Donk, Wilfred A (2016) Cameo appearances of aminoacyl-tRNA in natural product biosynthesis. Curr Opin Chem Biol 35:29-36
Freestone, Todd S; Zhao, Huimin (2016) Combinatorial pathway engineering for optimized production of the anti-malarial FR900098. Biotechnol Bioeng 113:384-92
Wendt, Kristen E; Ungerer, Justin; Cobb, Ryan E et al. (2016) CRISPR/Cas9 mediated targeted mutagenesis of the fast growing cyanobacterium Synechococcus elongatus UTEX 2973. Microb Cell Fact 15:115
Luo, Yunzi; Enghiad, Behnam; Zhao, Huimin (2016) New tools for reconstruction and heterologous expression of natural product biosynthetic gene clusters. Nat Prod Rep 33:174-82
Peck, Spencer C; van der Donk, Wilfred A (2016) Go it alone: four-electron oxidations by mononuclear non-heme iron enzymes. J Biol Inorg Chem :
Blodgett, Joshua Av; Zhang, Jun Kai; Yu, Xiaomin et al. (2016) Conserved biosynthetic pathways for phosalacine, bialaphos and newly discovered phosphonic acid natural products. J Antibiot (Tokyo) 69:15-25

Showing the most recent 10 out of 99 publications